FDA approves Eisai's epilepsy drug

FDA approved epilepsy drug Fycompa perampanel from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) as adjunct treatment for partial onset seizures in patients with epilepsy ages 12 and older. The pharma will ...